A Randomized, Double-blind, Placebo-controlled, Phase III Trial to Evaluate the Efficacy and Safety of Intra-articular Injections of RTX-GRT7039 in Adult Subjects With Pain Associated With Osteoarthritis of the Knee
A Randomized, Double-blind, Placebo-controlled, Phase III Trial to Evaluate the Efficacy and Safety of Intra-articular Injections of RTX-GRT7039 in Adult Subjects With Pain Associated With Osteoarthritis of the Knee
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.
This trial comprises a total observation period of up to 52 weeks.
Inclusion Criteria:
Exclusion Criteria:
Sainte-Foy, Quebec G1V 3M7, Canada
Naples, 80138, Italy
Naples, 80138, Italy
Funabashi-shi, Chiba 273-8588, Japan
Mihara-shi, Hiroshima 723-8686, Japan
Yokohama, Kanagawa 222-0036, Japan
Nagano, Matsumoto-shi Nagano 390-8601, Japan
Aoba-ku, Sendai-shi 980-0803, Japan
Bunkyo-Ku, Tokyo 113-0033, Japan
Bunkyo-ku, Tokyo 113-0034, Japan
Minato-ku, Tokyo 108-8642, Japan
Nishimura, Wakayama 649-2211, Japan
Mexico City, Mexico City 11850, Mexico
Lublin, Lublin Voivodeship 20-607, Poland
Bialystok, Podlaskie Voivodeship 15-077, Poland